Literature DB >> 15539509

Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.

Dean T Nardelli1, Matthew A Burchill, Douglas M England, Jose Torrealba, Steven M Callister, Ronald F Schell.   

Abstract

CD4+ CD25+ T cells are a population of regulatory T cells responsible for active suppression of autoimmunity. Specifically, CD4+ CD25+ T cells have been shown to prevent insulin-dependent diabetes mellitus, inflammatory bowel disease, and pancreatitis. Here, we present evidence that CD4+ CD25+ T cells also play a major role in controlling the severity of arthritis detected in Borrelia burgdorferi-vaccinated gamma interferon-deficient (IFN-gamma degrees ) C57BL/6 mice challenged with the Lyme spirochete. When B. burgdorferi-vaccinated and challenged IFN-gamma degrees mice were treated with anti-interleukin-17 (IL-17) antibody, the number of CD4+ CD25+ T cells increased in the local lymph nodes. Furthermore, histopathologic examination showed the mice to be free of destructive arthritis. When these anti-IL-17-treated B. burgdorferi-vaccinated and challenged mice were also administered anti-CD25 antibody, the number of CD4+ CD25+ T cells in the local lymph nodes decreased. More importantly, severe destructive arthropathy was induced. In addition, delayed administration of anti-CD25 antibody decreased the severity of the arthritis. These results suggest that CD4+ CD25+ T cells are involved in regulation of a severe destructive arthritis induced with an experimental model of vaccination and challenge with B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539509      PMCID: PMC524754          DOI: 10.1128/CDLI.11.6.1075-1084.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  49 in total

1.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Authors:  M Itoh; T Takahashi; N Sakaguchi; Y Kuniyasu; J Shimizu; F Otsuka; S Sakaguchi
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

Authors:  S Kotake; N Udagawa; N Takahashi; K Matsuzaki; K Itoh; S Ishiyama; S Saito; K Inoue; N Kamatani; M T Gillespie; T J Martin; T Suda
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 3.  Cellular and acellular pertussis vaccines in adults.

Authors:  W A Keitel
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

4.  Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency.

Authors:  M Papiernik; M L de Moraes; C Pontoux; F Vasseur; C Pénit
Journal:  Int Immunol       Date:  1998-04       Impact factor: 4.823

6.  IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.

Authors:  C Albanesi; A Cavani; G Girolomoni
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

7.  Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.

Authors:  M A Antonysamy; W C Fanslow; F Fu; W Li; S Qian; A B Troutt; A W Thomson
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

8.  Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

Authors:  M B Teunissen; C W Koomen; R de Waal Malefyt; E A Wierenga; J D Bos
Journal:  J Invest Dermatol       Date:  1998-10       Impact factor: 8.551

9.  Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice.

Authors:  G J Thorbecke; R Shah; C H Leu; A P Kuruvilla; A M Hardison; M A Palladino
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; J R Creson; S D Lovrich; S M Callister; D A Jobe; R F Schell
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more
  23 in total

1.  Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism.

Authors:  Marije Oosting; Frank L van de Veerdonk; Thirumala-Devi Kanneganti; Patrick Sturm; Ineke Verschueren; Anneleen Berende; Jos W M van der Meer; Bart-Jan Kullberg; Mihai G Netea; Leo A B Joosten
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

2.  CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.

Authors:  Dean T Nardelli; Joseph P Cloute; K H Kevin Luk; Jose Torrealba; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

Review 3.  Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Authors:  Gerard E Kaiko; Jay C Horvat; Kenneth W Beagley; Philip M Hansbro
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

Review 4.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

5.  Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.

Authors:  Carrie E Lasky; Kara E Jamison; Darcie R Sidelinger; Carmela L Pratt; Guoquan Zhang; Charles R Brown
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

6.  Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells.

Authors:  Sunao Sugita; Shintaro Horie; Yukiko Yamada; Yuko Kawazoe; Hiroshi Takase; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2011-07-13       Impact factor: 2.447

7.  Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.

Authors:  Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2006-08

8.  Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.

Authors:  Joseph Kuo; Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

9.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

10.  Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.

Authors:  Nicholas J Kotloski; Dean T Nardelli; Sara Heil Peterson; Jose R Torrealba; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.